Company Profiles

driven by the PitchBook Platform

Allecra Therapeutics

Description

Developer of novel antibiotics to combat Gram-negative bacterial infections. The company has developed products intended to treat multi-drug-resistant infections.

2013

Founded

PRIVATE

Status

1-10

Employees

Series B

Latest Deal Type

$24.9M

Latest Deal Amount

$44.4M

Total Amount Raised

Description

Developer of novel antibiotics to combat Gram-negative bacterial infections. The company has developed products intended to treat multi-drug-resistant infections.

Website:

www.allecra.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Pharmaceuticals

Primary Office

Im Kränzliacker 9 79576 Weil am RheinGermany +49 (0)79 5922 005
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Allecra Therapeutics's full profile, request a free trial.

    Allecra Therapeutics Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Allecra Therapeutics Investors (5)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Delos Capital (Hong Kong)Venture CapitalMinority000 0000000 0000
    Edmond de Rothschild Investment PartnersPE/BuyoutMinority000 0000000 0000
    EMBL VenturesVenture CapitalMinority000 0000000 0000
    Forbion Capital PartnersVenture CapitalMinority000 0000000 0000
    Orchid PharmaVC-Backed CompanyMinority000 0000000 0000
    Delos Capital (Hong Kong) Venture Capital
    Edmond de Rothschild Investment Partners PE/Buyout
    EMBL Ventures Venture Capital
    Forbion Capital Partners Venture Capital
    Orchid Pharma VC-Backed Company

    Allecra Therapeutics Executive Team (6)

    NameTitleBoard
    Seat
    Contact
    Info
    Nicholas BenedictCo-Founder & Chief Executive Officer
    Brice SuireChief Financial Officer
    Omar Lalhou Ph.DDirector, Regulatory Affairs
    Stefano BiondiHead of Chemistry, Manufacturing and Controls
    Marcin Mankowski MDChief Medical Officer
    Nicholas Benedict Co-Founder & Chief Executive Officer
    Brice Suire Chief Financial Officer
    Omar Lalhou Ph.D Director, Regulatory Affairs
    Stefano Biondi Head of Chemistry, Manufacturing and Controls
    Marcin Mankowski MD Chief Medical Officer

    Allecra Therapeutics Board Members (4)

    NameRepresentingRoleSinceContact
    Info
    Henry Chen JDDelos Capital (Hong Kong)Co-Founder & Managing Partner000 0000
    Holger Reithinger Ph.DForbion Capital PartnersGeneral Partner000 0000
    Olivier Litzka Ph.DEdmond de Rothschild Investment PartnersPartner000 0000
    Tim XiaoDelos Capital (Hong Kong)Principal000 0000
    Henry Chen JD Co-Founder & Managing Partner Delos Capital (Hong Kong)
    Holger Reithinger Ph.D General Partner Forbion Capital Partners
    Olivier Litzka Ph.D Partner Edmond de Rothschild Investment Partners
    Tim Xiao Principal Delos Capital (Hong Kong)
    Request full access to PitchBook